Titled “Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis,” the study was published in the journal Neurology and Urodynamics.
People with MS can present with a wide variety of clinical symptoms that affect various organs, including those outside of the central nervous system.
Lower urinary tract symptoms, or LUTS, tend to affect up to 80% of MS patients. These symptoms — which include any dysfunction related to urinating, such as difficulty emptying the bladder and problems storing urine — tend to change as MS evolves, and have been shown to have a negative impact on patients’ quality of life.
Therefore, urological management of MS patients is essential for maintaining an optimal quality of life, and preventing urological complications.
In most cases, people with MS who have urological problems are prescribed conventional therapies that are administered either orally or through an injection. However, these therapies can sometimes be insufficient to control LUTS.
In such cases, a surgical approach using non-continent urinary diversion may be an option. Urinary diversion is a surgical procedure that creates a new way for urine to pass out of the body.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?